Amazon.com results were in line with Street estimates on Thursday, but its guidance came in light.» Read More
Garmin, a maker of GPS-based devices, reported better-than-expected quarterly revenue and profit as demand surged for its fitness products.
Shares in Fiat Chrysler rose more than 18 percent after announcing plans to spin off its luxury car unit Ferrari and issue a convertible bond.
Total warned that sliding oil prices had hit its third-quarter results and could weigh for the rest of 2014.
Norwegian energy firm reports an unexpected third-quarter net loss, weighed down by impairment charges on projects from Canada to Angola.
Deutsche Bank posts a surprise net loss in its third-quarter earnings, as heavy legal costs outweighed a rise in investment banking.
Gilead Sciences reported Tuesday that sales of its Hepatitis C drug, Sovaldi, fell nearly 20 percent from the prior quarter.
The social media giant reported third-quarter earnings of 43 cents per share, versus expectations of 40 cents per share.
Department store Kohl's warned investors that it expects its earnings this year to come in at the low end of its prior guidance.
Coach reported a better-than-expected profit, helped by strong demand for its products in China, sending its shares up in premarket trading.
Swiss drugmaker Novartis reported better-than-expected results on Tuesday, as strong sales of new products helped offset the expiration of a key patent.
Whirlpool posted a higher profit on increased sales of its washers and dryers, cooktops, stoves, and refrigerators in North America and Europe.
TD Ameritrade said profit climbed 5.5 percent on a jump in net new assets, and forecast asset growth of 7 to 11 percent in 2015.
Pfizer earnings topped analysts' expectations on Tuesday, helped by demand for its cancer drugs and medicines in emerging markets.
DuPont reported a 52 percent jump in profit as operating margins rose in five of its seven businesses.
BP increased dividends as it saw a jump in operating cash flow, despite lower oil prices and a drop in contributions from Russia.
Shares of Sanofi tumbled around 7.4 percent early on Tuesday after the French drugmaker reported weaker-than-expected Q3 sales.
Taxpayer-backed lender Lloyds has confirmed its plans to cut around 9,000 jobs as it reported its underlying profit rose to £2.1 billion.
UBS posted forecast-beating net profits of $802 million but warned on litigation charges of $1.9 billion.
Twitter reported third-quarter earnings on Monday, meeting analysts' estimates for profits and beating on revenue.
Amgen reported better-than expected quarterly results and said it projects full-year earnings and revenue to come in above analysts' forecasts.